Clinical Trial Update: Extracorporal Photopheresis With UVADEX Plus Standard Steroid Treatment for High Risk Acute Graft-versus-host Disease [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating extracorporeal photopheresis with UVADEX plus standard steroids for high-risk acute graft-versus…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• UVADEX (methoxsalen)

Snippet

Sponsor: Universitätsklinikum Hamburg-Eppendorf | Conditions: Acute-graft-versus-host Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING